Search results for: “diet “
-
Panelists to outline impact of youth substance use on diabetes care
Elissa Weitzman, ScD, MSc, will be part of a trio of presenters in an Ask the Experts session focused on how to integrate conversations about the use of tobacco, alcohol, cannabis, pain medications, and other substances into clinical care for young people living with diabetes.
-
Symposium to examine AI’s current and near-future impact on diabetes tech
Boris Kovatchev, PhD, and other panelists will share recent developments in the application of artificial intelligence in automated insulin delivery, clinical decision-making, nutrition estimation, diabetes coaching, and more.
-
Presenter Profile: Effects of Sugar and Non-Nutritive Sweeteners on Brain and Metabolic Health
Katie Page, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Presenter Profile: Metabolic Consequences of Current Cancer Therapies
Sonali Thosani, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 1:30 p.m. CT.
-
Presenter Profile: A Mitochondrial Carrier Connects Circadian Rhythms to Thermogenic Lipid Cycling in Adipose Tissue
Zach Gerhart-Hines, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
-
Presenter Profile: Leveraging Multimodal Monitoring to Ascertain Intraindividual Diabetes Subphenotypes
Jessilyn Dunn, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Presenter Profile: The Mitochondrial Pyruvate Carrier Governs Skeletal Muscle Metabolic Flexibility
Katsu Funai, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
-
Experts to review the benefits and challenges of GLP-1 RAs beyond diabetes and obesity
Investigators will give an overview of new therapies coming into the market. Panelist Donna Ryan, MD, will discuss clinical trials for incretin-based therapies.
-
Monoclonal antibody-peptide conjugate demonstrates efficacy as once-monthly treatment for obesity
Researchers, including Ania M. Jastreboff, MD, PhD, detailed the results of a phase 2 study of maridebart cafraglutide for inducing weight loss in adults living with obesity, with or without type 2 diabetes.
-
Kelly West Award recipient combines data-driven knowledge with care
In her award lecture, epidemiologist Juliana C.N. Chan, MBChB, MD, FHKAM, FHKCP, FRCP, detailed her decades of data-driven research and her personal experience working with patients in a major metropolis transformed by global modernization.